Missed dose: difference between revisions
Diff·revision 10 → 11·11:20, 25 Mar 2025
Difference between revision 10 and revision 11 of Missed dose. 2 lines changed; the page grew by 284 bytes.
| Revision 10 — 11:28, 26 Feb 2025 CategoryBot (talk) bot: repair redlinked category 4,123 bytes ±0 | Revision 11 — 11:20, 25 Mar 2025 ArchiveBot (talk) bot: normalise unit spacing 4,407 bytes +284 | ||
|---|---|---|---|
| 32 | The windows differ between products because the half-lives differ, which is why a rule learned for one product does not transfer to another. This is a specific instance of the general point that class membership does not imply interchangeability. See [[GLP-1 receptor agonist]]. | 32 | The windows differ between products because the half-lives differ, which is why a rule learned for one product does not transfer to another. This is a specific instance of the general point that class membership does not imply interchangeability. See [[GLP-1 receptor agonist]]. |
| 33 | 33 | ||
| + | 34 | Doubling a dose to compensate for an omission is not what any labelling in this class directs, and the pharmacokinetics do not support it: a double dose produces a peak exposure outside the studied range, which is where the dose-related adverse effects concentrate.{{r|knudsen2019}} | |
| + | 35 | ||
| 34 | == References == | 36 | == References == |
| 35 | {{reflist}} | 37 | {{reflist}} |